PICATINNY ARSENAL, N.J. – The U.S. Army’s Joint Program Executive Office Armaments & Ammunition and U.S. Army Contracting ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback